[1]Fujiwara T. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies[J]. Epilepsy Res,2006,6(27):S223-S230.
[2]Gataullina S, Dulac O. From genotype to phenotype in Dravet disease[J]. Seizure,2017,2(44):58-64.
[3]Yang L, Wu D, Tang JL.Clinical and molecular genetics of 3 cases of Dravet syndrome[J]. Chinese Journal of Child Health Care, 2016,24(10):1037-1040. (in Chinese)
杨李,吴德,唐久来. Dravet综合征3例临床及分子遗传学研究[J]. 中国儿童保健杂志,2016,24(10):1037-1040.
[4] Lin XT, Zhang P, Yu DL. Clinical characteristics and genetic type analysis of two cases of Dravet syndrome[J]. Chinese Journal of Birth Health and Heredity, 2015,23(1):119-120,114. (in Chinese)
林晓婷,张萍,于冬丽. 二例Dravet综合征临床特点和基因类型分析[J]. 中国优生与遗传杂志,2015,23(1):119-120,114.
[5]Schutte SS, Schutte RJ, Barragan EV, et al. Model systems for studying cellular mechanisms of SCN1A- related epilepsy[J]. J Neurophysiol,2016,115(4):1755-1766.
[6]Lim BC, Hwang H, Kim H, et al. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome[J]? Epilepsy Res,2015,2(109):34-39.
[7]Gontika MP, Konialis C, Pangalos C, et al. Novel SCN1A and GABRA1 gene mutations with diverse phenotypic features and the question on the existence of a broader spectrum of dravet syndrome[J]. Child Neurol Open,2017,5(8):2329048X-17706794X.
[8]Connolly MB. Dravet syndrome: diagnosis and long-term course[J]. Can J Neurol Sci,2016,6(43):S3-S8.
[9]Zhou Q, Zhang Q, Li GQ. Effects of resveratrol on expression of Toll-like receptor 4, nuclear factor-κB and Caspase-3 in hippocampus of seizures in rats[J]. Acta Anatomica Sinica,2014,45(3):321-327. (in Chinese)
周琴,张勤,李光乾. 白藜芦醇对惊厥持续状态大鼠海马Toll样受体4、核因子-κB、Caspase-3表达的影响[J]. 解剖学报,2014,45(3):321-327.
[10]Shmuely S, Sisodiya SM, Gunning WB, et al. Mortality in Dravet syndrome: a review[J]. Epilepsy Behav,2016,64(Pt A):69-74.
[11]Guo JZh, Li YL, Zhong LM, et al. Effect of resveratrol on endogenous mercaptan antioxidant (enzyme) in hippocampus of rats with epilepsy persistence[J]. Acta Anatomica Sinica, 2011,42(5):582-587. (in Chinese)
郭家智,李燕玲,钟莲梅,等. 白藜芦醇调控癫痫持续状态大鼠海马内源性巯醇抗氧化剂(酶)的作用[J]. 解剖学报,2011,42(5):582-587.
[12]Tuncer FN, Gormez Z, Calik M, et al. A clinical variant in SCN1A inherited from a mosaic father cosegregates with a novel variant to cause Dravet syndrome in a consanguineous family[J]. Epilepsy Res,2015,7(113):5-10.
[13]Ni Y, Zhang LM, Wu BB, et al. Clinical analysis of Dravet syndrome and SCNIA gene mutation(report of 60 cases)[J]. Chinese Journal of Practical Pediatrics, 2017,(10):772-776. (in Chinese)
倪燕,张林妹,吴冰冰,等. Dravet综合征临床与SCNIA基因突变分析(附60例报告)[J]. 中国实用儿科杂志,2017,(10):772-776.
[14]Carvill GL, Weckhuysen S, Mcmahon JM, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome[J]. Neurology,2014,82(14):1245-1253.
[15]Liu A, Xu X, Yang X, et al. The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population[J]. Clin Genet,2017,91(1):54-62.
[16]Claes L, DelFavero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy[J]. Am J Hum Genet,2001,68(6):1327-1332.
[17]Guo JCh, Zhao W. SCN1A gene changes in the incidence of familial febrile seizures[J]. Journal of Clinical Pediatrics, 2017,35(2):133-137. (in Chinese)
郭嘉诚,赵武. SCN1A基因变化在家族性热性惊厥发病中的作用[J]. 临床儿科杂志,2017,35(2):133-137.
[18]Petrelli C, Passamonti C, Cesaroni E, et al. Early clinical features in Dravet syndrome patients with and without SCN1A mutations[J]. Epilepsy Res,2012,99(1-2):21-27.
[19]Wang JW, Shi XY, Kurahashi H, et al. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy[J]. Epilepsy Res,2012,102(3):195-200.
[20]Le Gal F, Lebon S, Ramelli GP, et al. When is a child with status epilepticus likely to have Dravet syndrome [J] ? Epilepsy Res,2014,108(4):740-747.
[21]Li D, Huang ShP, Song TT, et al. Clinical analysis of children with Dravet syndrome in SCN1A gene mutation[J]. Journal of Xi’an Jiaotong University (Medical Sciences), 2016,37(6):841-845. (in Chinese)
李丹,黄绍平,宋婷婷,等. SCN1A基因突变阳性的Dravet综合征患儿的临床特征分析[J]. 西安交通大学学报(医学版),2016,37(6):841-845.
[22]Ragona F, Brazzo D, De Giorgi Ⅰ, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients[J]. Brain Dev,2010,32(1):71-77.
[23]Chen ZhN. Clinical and brain electrocardiogram of Dravet syndrome[J]. Journal of Modern Electrophysiology, 2012,19(1):32-37. (in Chinese)
陈芷若. Dravet综合征的临床和脑心电图[J]. 现代电生理学杂志,2012,19(1):32-37.
[24]Cetica Ⅴ, Chiari S, Mei D, et al. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations[J]. Neurology,2017,88(11):1037-1044.
[25]Lee HF, Chi CS, Tsai CR, et al. Electroencephalographic features of patients with SCN1A- positive Dravet syndrome[J]. Brain Dev,2015,37(6):599-611.
|